메뉴 건너뛰기




Volumn 7, Issue 9, 2012, Pages

Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRIC HYDROXIDE SUCROSE;

EID: 84866649581     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045604     Document Type: Article
Times cited : (47)

References (25)
  • 1
    • 33644653558 scopus 로고    scopus 로고
    • Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study
    • Schroder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, et al. (2005) Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 100: 2503-2509.
    • (2005) Am J Gastroenterol , vol.100 , pp. 2503-2509
    • Schroder, O.1    Mickisch, O.2    Seidler, U.3    de Weerth, A.4    Dignass, A.U.5
  • 2
    • 43549115913 scopus 로고    scopus 로고
    • Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease
    • Gisbert JP, Gomollon F, (2008) Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 103: 1299-1307.
    • (2008) Am J Gastroenterol , vol.103 , pp. 1299-1307
    • Gisbert, J.P.1    Gomollon, F.2
  • 3
    • 0034838979 scopus 로고    scopus 로고
    • A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients
    • Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, et al. (2001) A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrol Dial Transplant 16: 1879-1884.
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 1879-1884
    • Johnson, D.W.1    Herzig, K.A.2    Gissane, R.3    Campbell, S.B.4    Hawley, C.M.5
  • 4
    • 63049092549 scopus 로고    scopus 로고
    • Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study
    • Kim YH, Chung HH, Kang SB, Kim SC, Kim YT, (2009) Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. Acta Haematol 121: 37-41.
    • (2009) Acta Haematol , vol.121 , pp. 37-41
    • Kim, Y.H.1    Chung, H.H.2    Kang, S.B.3    Kim, S.C.4    Kim, Y.T.5
  • 5
    • 52949101033 scopus 로고    scopus 로고
    • Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial
    • Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, et al. (2008) Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 199: 435-437.
    • (2008) Am J Obstet Gynecol , vol.199 , pp. 435-437
    • Seid, M.H.1    Derman, R.J.2    Baker, J.B.3    Banach, W.4    Goldberg, C.5
  • 6
    • 44249107891 scopus 로고    scopus 로고
    • The use of intravenous iron in patients with cancer-related anaemia
    • Littlewood TJ, Alikhan R, (2008) The use of intravenous iron in patients with cancer-related anaemia. Br J Haematol 141: 751-756.
    • (2008) Br J Haematol , vol.141 , pp. 751-756
    • Littlewood, T.J.1    Alikhan, R.2
  • 7
    • 70350648478 scopus 로고    scopus 로고
    • Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study
    • Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, et al. (2009) Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 44: 838-845.
    • (2009) Scand J Gastroenterol , vol.44 , pp. 838-845
    • Lindgren, S.1    Wikman, O.2    Befrits, R.3    Blom, H.4    Eriksson, A.5
  • 8
    • 43549093318 scopus 로고    scopus 로고
    • A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial
    • Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, et al. (2008) A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 103: 1182-1192.
    • (2008) Am J Gastroenterol , vol.103 , pp. 1182-1192
    • Kulnigg, S.1    Stoinov, S.2    Simanenkov, V.3    Dudar, L.V.4    Karnafel, W.5
  • 9
    • 33748262238 scopus 로고    scopus 로고
    • High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis
    • Seril DN, Liao J, West AB, Yang GY, (2006) High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. J Clin Gastroenterol 40: 391-397.
    • (2006) J Clin Gastroenterol , vol.40 , pp. 391-397
    • Seril, D.N.1    Liao, J.2    West, A.B.3    Yang, G.Y.4
  • 10
    • 65349182361 scopus 로고    scopus 로고
    • Safety issues with intravenous iron products in the management of anemia in chronic kidney disease
    • Hayat A, (2008) Safety issues with intravenous iron products in the management of anemia in chronic kidney disease. Clin Med Res 6: 93-102.
    • (2008) Clin Med Res , vol.6 , pp. 93-102
    • Hayat, A.1
  • 12
    • 80051760519 scopus 로고    scopus 로고
    • Análisis farmacoeconómico del tratamiento de la deficiencia de hierro con hierro carboximaltosa (Ferinject®) en España
    • Rubio C, (2010) Análisis farmacoeconómico del tratamiento de la deficiencia de hierro con hierro carboximaltosa (Ferinject®) en España. PharmacoEconomics- Spanish Research articles 7: 109-117.
    • (2010) PharmacoEconomics- Spanish Research Articles , vol.7 , pp. 109-117
    • Rubio, C.1
  • 13
    • 80052108611 scopus 로고    scopus 로고
    • FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease
    • Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, et al. (2011) FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 141: 846-853.
    • (2011) Gastroenterology , vol.141 , pp. 846-853
    • Evstatiev, R.1    Marteau, P.2    Iqbal, T.3    Khalif, I.L.4    Stein, J.5
  • 14
    • 77956396228 scopus 로고    scopus 로고
    • Use of intravenous iron infusion in a gastroenterology day hospital: Indications, dosage and adverse effects
    • Dosal A, Calvet X, Moreno L, López M, Figuerola A, et al. (2010) Use of intravenous iron infusion in a gastroenterology day hospital: Indications, dosage and adverse effects. Gastroenterol Hepatol 33: 479-483.
    • (2010) Gastroenterol Hepatol , vol.33 , pp. 479-483
    • Dosal, A.1    Calvet, X.2    Moreno, L.3    López, M.4    Figuerola, A.5
  • 15
    • 84876199689 scopus 로고    scopus 로고
    • Consejo General de Colegios Oficiales de Farmacéuticos website. Available: https://botplusweb.portalfarma.com/. Accessed 2010 Sep 15.
  • 16
    • 77957323453 scopus 로고    scopus 로고
    • The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective
    • Bager P, Dahlerup JF, (2010) The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. J Crohns Colitis 4: 427-430.
    • (2010) J Crohns Colitis , vol.4 , pp. 427-430
    • Bager, P.1    Dahlerup, J.F.2
  • 17
    • 84876203679 scopus 로고    scopus 로고
    • List of countries in Europe by monthly average wage. Available: http://en.wikipedia.org/wiki/List_of_countries_in_Europe_by_monthly_average_wage. Accessed 2012 May 8.
  • 18
    • 65949107825 scopus 로고    scopus 로고
    • Ferric carboxymaltose: a review of its use in iron-deficiency anaemia
    • Lyseng-Williamson KA, (2009) Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 69: 739-759.
    • (2009) Drugs , vol.69 , pp. 739-759
    • Lyseng-Williamson, K.A.1
  • 19
    • 77956806828 scopus 로고    scopus 로고
    • The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review
    • Qunibi WY, (2010) The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review. Arzneimittelforschung 60: 399-412.
    • (2010) Arzneimittelforschung , vol.60 , pp. 399-412
    • Qunibi, W.Y.1
  • 20
    • 77954847982 scopus 로고    scopus 로고
    • Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency
    • Kociol RD, Newby LK, (2010) Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency. Ann Intern Med 152: JC4-JC5.
    • (2010) Ann Intern Med , vol.152
    • Kociol, R.D.1    Newby, L.K.2
  • 21
    • 77954797927 scopus 로고    scopus 로고
    • The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study
    • Covic A, Mircescu G, (2010) The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study. Nephrol Dial Transplant 25: 2722-2730.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 2722-2730
    • Covic, A.1    Mircescu, G.2
  • 22
    • 64549090727 scopus 로고    scopus 로고
    • Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients
    • Grimmelt AC, Cohen CD, Fehr T, Serra AL, Wuethrich RP, (2009) Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients. Clin Nephrol 71: 125-129.
    • (2009) Clin Nephrol , vol.71 , pp. 125-129
    • Grimmelt, A.C.1    Cohen, C.D.2    Fehr, T.3    Serra, A.L.4    Wuethrich, R.P.5
  • 24
    • 77956855555 scopus 로고    scopus 로고
    • Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications
    • Bailie GR, (2010) Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittelforschung 60: 386-98.
    • (2010) Arzneimittelforschung , vol.60 , pp. 386-398
    • Bailie, G.R.1
  • 25
    • 77349120060 scopus 로고    scopus 로고
    • Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
    • Bailie GR, Mason NA, Valaoras TG, (2010) Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodial Int 14: 47-54.
    • (2010) Hemodial Int , vol.14 , pp. 47-54
    • Bailie, G.R.1    Mason, N.A.2    Valaoras, T.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.